Corporate Profile Æterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, multiple myeloma, endometrial, ovarian, prostate and bladder cancer.The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. Pipeline: http://www.aeternazentaris.com/en/page.php?p=23 News: Yahoo feed: http://finance.yahoo.com/q?s=aezs&ql=1 iHub feed: http://ih.advfn.com/p.php?pid=news&symbol=N%5EAEZS Contacts: Canada Æterna Zentaris Inc. 1405 du Parc-Technologique Blvd. Québec, Québec Canada G1P 4P5 Phone: (418) 652-8525 Fax: (418) 652-0881 USA Æterna Zentaris, Inc. 100 MarketPlace Suite 203 25 Mountainview Blvd. Basking Ridge, NJ 07920 Phone: (908) 626-5428 Fax: (908) 626-5427 Investor Relations Ginette Vallières Investor Relations Coordinator (418) 652-8525 gvallieres@aezsinc.com Investor Fact Sheet: http://www.aeternazentaris.com/en/page.php?p=53 Website: http://www.aeternazentaris.com Clinical Trials: http://clinicaltrials.gov/ct2/results?term=AEZS&Search=Search Charts: Gallery views: http://stockcharts.com/freecharts/gallery.html?aezs Daily three months: